CTSH
52
-3
MKC
65
2
PCAR
55
3
HD
52
-5
ICE
63
4
GME
57
-3
XRAY
46
2
PHM
58
-2
BAC
45
-2
MO
51
-2
BA
63
5
EFX
44
-5
WM
65
-3
ACN
50
3
DG
27
4
SPG
51
-5
KR
56
11
MTCH
48
-5
VFC
53
-6
PAYX
50
3
CTSH
52
-3
MKC
65
2
PCAR
55
3
HD
52
-5
ICE
63
4
GME
57
-3
XRAY
46
2
PHM
58
-2
BAC
45
-2
MO
51
-2
BA
63
5
EFX
44
-5
WM
65
-3
ACN
50
3
DG
27
4
SPG
51
-5
KR
56
11
MTCH
48
-5
VFC
53
-6
PAYX
50
3
Financhill
Back

KalVista Pharmaceuticals Vs. Perspective Therapeutics Industry Stock Comparison

Buy
51

KALV
KalVista Pharmaceuticals

Last Price:
9.11
Seasonality Move:
13.48%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.47
Seasonality Move:
22.12%
Buy
51
KalVista Pharmaceuticals (KALV) is a Buy

Is KalVista Pharmaceuticals a Buy, Sell or Hold?

  • The current KalVista Pharmaceuticals [KALV] share price is $9.44. The Score for KALV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • KALV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.65. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KALV Stock Price Chart

What is KalVista Pharmaceuticals's stock price today?

  • The KalVista Pharmaceuticals share price today is $9.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

KALV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 42.65 Sell
Chaikin Money Flow: 86108 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.28 - 10.78) Sell
Bollinger Bands (100): (10.14 - 13.18) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.86 Sell
Relative Strength Index (14 RSI): 22.83 Sell
Chaikin Money Flow: -248346 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 9.93) Sell
Bollinger Bands (100): (8.15 - 15.19) Sell

KALV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.65 Sell
20-day SMA: 9.73 Sell
50-day SMA: 10.83 Sell
200-day SMA: 11.89 Sell
8-day EMA: 9.58 Sell
20-day EMA: 9.9 Sell
50-day EMA: 10.56 Sell
200-day EMA: 11.42 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.89 Sell
20-day SMA: 5.36 Sell
50-day SMA: 9.58 Sell
200-day SMA: 12.45 Sell
8-day EMA: 3.97 Sell
20-day EMA: 5.5 Sell
50-day EMA: 8.4 Sell
200-day EMA: 10.58 Sell

KalVista Pharmaceuticals Earnings Growth & KALV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.40 per share, and a decrease next year of $0.61 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

KalVista Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):